Despite the diversity of the symptoms and the heterogeneity of the clinical presentation, aggregation of α-synuclein along relevant neuronal networks in the autonomic nervous system, brainstem, and cortex has provided a unifying molecular mechanism for therapeutic intervention in PD [3]. Here, SNCA is linked to Parkinson disease.